Samsung to buy digital health company Xealth
Samsung has announced its plans to acquire digital health company Xealth, marking a significant move in the integration of data from wearable devices into clinical care. The acquisition aims to bridge the gap between wellness data collected at home and medical care in healthcare settings.
Xealth's digital health platform, already used by over 500 hospitals and 30 large health systems, enables the integration and management of various digital health tools directly into clinical workflows. By combining Samsung's wearables and home health monitoring technologies with Xealth’s platform, the acquisition intends to unify fragmented health data, allowing clinicians to access more comprehensive patient information for better clinical decision-making and enabling more seamless, connected care between patients and providers.
The Samsung Galaxy Watch wearable has already received FDA clearance to detect irregular heart rhythms and signs of sleep apnea. With the integration of Xealth's platform, providers can more easily prescribe, monitor, and act upon data from wearable devices just as they would with traditional medical interventions. This move supports Samsung’s vision of turning its devices—such as smartwatches, phones, and TVs—into comprehensive ambient health monitoring tools in the home environment, further embedding wearable data into clinical contexts over time.
Xealth CEO Mike McSherry emphasized that the effort will focus on creating a bridge between home health monitoring and clinical decision-making, with provider workflow and patient engagement at its core. This acquisition is expected to help ensure data from consumer wellness products can be shared more easily with providers, further advancing truly connected care.
The specific financial terms of the Samsung-Xealth acquisition were not disclosed. However, the deal is not the first M&A in the digital health sector this year, as M&A activity is increasing. According to a report published this week by Rock Health, there were 107 digital health M&A deals in the first half of the year, on track to outpace the 121 transactions recorded in 2024. The acquisition bolsters Samsung's goal to unify fragmented health information and is part of a larger trend of M&A activity in the digital health sector.
The acquisition is expected to close this year. With the integration of Xealth's platform, Samsung is positioning itself to accelerate the clinical validation and use of wearable health data within healthcare systems by embedding this data into provider workflows and electronic medical records. This move is expected to bring us a step closer to a seamless integration of wellness and medical care.
[1] Samsung to acquire digital health company Xealth [2] Samsung's Galaxy Watch receives FDA clearance for heart rhythm and sleep apnea detection [3] Xealth aims to bridge home health monitoring and clinical decision-making [4] Xealth's digital health platform enables integration and management of various digital health tools directly into clinical workflows
[5] The acquisition of Xealth by Samsung will assist in unifying fragmented health data for better clinical decision-making.[6] With the integration of Xealth's platform, Samsung aims to embed wearable data into clinical contexts for more seamless, connected care.[7] The deal is part of a larger trend of M&A activity in the digital health sector, with the acquisition expected to close this year, bolstering Samsung's goal to advance connected care and healthcare analytics.
